Testing effectiveness (Phase 2)Not Yet RecruitingNCT07375524
What this trial is testing
Study on the Safety and Efficacy of the Anti-BAFF-R Monoclonal Antibody, ESG206, in Patients With Primary Sjogren Syndrome
Who this might be right for
Primary Sjögren Syndrome
Shanghai Escugen Biotechnology Co., Ltd 40